Pathogenesis & Infection | Research Interests

Name	Email	PhD Program
Khetan, Pri EMAIL	PHD PROGRAM RESEARCH INTEREST Pathogenesis & Infection, Virology	“I am interested in understanding the various host and viral factors involved in the establishment and persistence of viral infections. Another avenue I want to explore involves harnessing the immune system and host factors essentially for viral pathogenesis to clear infections.”
Rueppell, Anika EMAIL	PHD PROGRAM RESEARCH INTEREST Bacteriology, Immunology, Pathogenesis & Infection	“I am interested in exploring how host immune systems and infectious agents affect one another and how these interactions impact disease outcomes. Some questions that interest me include how immune responses to pathogens can increase symptoms or change disease outcomes, how pathogens can take advantage of altered/compromised immunity, and how the combined variability of pathogen populations and human immunity can cause variable disease states. In particular, I am interested in bacteria in the respiratory and/or gastrointestinal systems.”
Rowe-Conlon, Sarah WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Microbiology & Immunology RESEARCH INTEREST Antibiotics/Antivirals, Bacteriology, Diabetes, Drug Delivery, Drug Discovery, Pathogenesis & Infection, Pharmacology, Translational Medicine	My lab studies recalcitrant bacterial infections and antibiotic treatment failure. Focusing on bacteremia and wound infection, we utilize a range of in vitro, tissue culture and mouse models to understand the precise nature of treatment failure and exploit this knowledge to modulate antibiotic activity in the host environment. My long-term goal is to bring improved therapeutic strategies to the bedside.
Ehre, Camille WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Microbiology & Immunology RESEARCH INTEREST Cell Biology, Microscopy/Imaging, Pathogenesis & Infection, Pulmonary Research, Respiratory Physiology & Infections	The Ehre laboratory studies the role of mucus in obstructive pulmonary diseases, such as asthma, and cystic fibrosis (CF), as well as in response to respiratory viruses (SARS-CoV-2 and RSV). Our research goal is to gain insights into the basic defects of airway mucus that lead to impaired mucociliary clearance and viral penetration. We use in vitro and in vivo models to study disease pathogenesis, test pharmacological agents and investigate how mucus obstruction and viral infection cause epithelial damage. In addition, we examine patient specimens to understand the role of inflammatory cytokines in disease severity. For these projects, we use integrative omics technologies (transcriptomics, digital spatial profiler, phenocycler) and high-resolution imaging (live, laser and scanning/transmission electron microscopy) to answer critical questions regarding mucus biology and airways response to inhaled pathogens and/or treatment.
Good, Misty WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Microbiology & Immunology, Pathobiology & Translational Science RESEARCH INTEREST Cell Biology, Developmental Biology, Gastrointestinal Biology, Human Subjects Research, Immunology, Molecular Mechanisms of Disease, Pathogenesis & Infection, Stem Cells	The Good Laboratory is focused on the cellular and molecular mechanisms involved in the pathogenesis of a devastating intestinal disease primarily affecting premature infants called necrotizing enterocolitis (NEC). The long-term goal of the Good Lab is to understand the signaling pathways regulating the uncontrolled immune response in NEC and how these responses can be prevented through dietary modifications or targeted intestinal epithelial therapies. Her basic and translational research utilizes a bench-to-bedside approach with multiple cutting-edge techniques. In her pre-clinical studies, their team utilizes a humanized neonatal mouse model of NEC to understand the signaling pathways and immune cell responses involved in NEC development. Specifically, the laboratory interrogates ways to modulate the immune response, epithelial cell and stem cell regeneration as well as early microbial colonization during NEC. In the clinical component of her research program, Dr. Good leads a large multi-center NEC biorepository for the dedicated pursuit of molecular indicators of disease and to gain greater pathophysiologic insights during NEC in humans. Dr. Good also developed a premature infant intestine-on-a-chip model to study NEC and provide a personalized medicine approach to test new therapeutics. Her laboratory is currently funded with multiple NIH R01 grants and has previously received K08 and R03 funding as well as awards from the March of Dimes, the Gerber Foundation and the NEC Society.
Livraghi-Butrico, Alessandra WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Microbiology & Immunology RESEARCH INTEREST Pathogenesis & Infection, Pulmonary Research, Respiratory Physiology & Infections, Translational Medicine	The Livraghi-Butrico lab is focused on exploring the key determinants of effective airway mucus clearance in health, as well as the consequences of its derangement in muco-obstructive lung diseases. Our lab leverages the unparalleled functional integration offered by in vivo animal models to test mechanistic hypotheses and vet therapeutic options for pre-clinical development.
Rosenthal, Adam WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Microbiology & Immunology RESEARCH INTEREST Bacteriology, Molecular Biology, Pathogenesis & Infection, Systems Biology	Our lab uses a systems biology approach to study phenotypic heterogeneity in bacteria. We develop tools that quantify single cell bacterial transcription. We then compare dynamic measurements during vegetative growth and infection to identify regulators of gene expression and mechanisms that bacteria use to coordinate community organization. With this data we want to understand the role of heterogeneity and noise in infectious disease.
Thurlow, Lance EMAIL PUBLICATIONS	PHD PROGRAM Microbiology & Immunology RESEARCH INTEREST Bacteriology, Cell Signaling, Immunology, Metabolism, Pathogenesis & Infection	By 2035, more than 500 million people worldwide will be diagnosed with diabetes. Individuals with diabetes are prone to frequent and invasive infections that commonly manifest as skin and soft tissue infections (SSTIs). Staphylococcus aureus is the most commonly isolated pathogen from diabetic SSTI. S. aureus is a problematic pathogen that is responsible for tens of thousands of invasive infections and deaths annually in the US. Most S. aureus infections manifest as skin and soft tissue infections (SSTIs) that are usually self-resolving. However, in patients with comorbidities, particularly diabetes, S. aureus SSTIs can disseminate resulting in systemic disease including osteomyelitis, endocarditis and sepsis. The goal of my research is to understand the complex interactions between bacterial pathogens and the host innate immune response with focus on S. aureus and invasive infections associated with diabetes. My research is roughly divided into two project areas in order to understand the contributions of the pathogen and the host response to invasive infections associated with diabetes. Project 1: Defining mechanisms of immune suppression in diabetic infections. Project 2: Determine the role of bacterial metabolism in virulence potential and pathogenesis.
Sheahan, Tim WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Microbiology & Immunology RESEARCH INTEREST Drug Discovery, Pathogenesis & Infection, Virology	Dr. Sheahan is an expert virologist with a primary appointment in the Department of Epidemiology in the Gillings School of Global Public Health and a secondary appointment in Microbiology and Immunology in the School of Medicine. His research is focused on understanding emerging viral diseases and developing new means to stop them with a current focus on coronavirus and hepacivirus.
Lin, Jessica WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Microbiology & Immunology RESEARCH INTEREST Genetics, Genomics, Molecular Biology, Molecular Medicine, Pathogenesis & Infection	Dr. Lin is an infectious disease physician-scientist whose research lies at the interface of clinical and molecular studies on malaria. My current projects focus on 1) determinants of malaria transmission from human hosts to mosquitos and 2) the epidemiology and relapse patterns of Plasmodium ovale in East Africa. Work in my lab involves applying molecular tools (real-time PCR, amplicon deep sequencing, whole genome sequencing, and to a lesser extent antigen and antibody assays) to samples collected in clinical field studies to learn about malaria epidemiology, transmission, and pathogenesis.

Research Interest: Pathogenesis & Infection